Armata Pharmaceuticals (ARMP) Shares Outstanding (Weighted Average) (2013 - 2026)

Armata Pharmaceuticals has disclosed Shares Outstanding (Weighted Average) across 14 years of filings, most recently posting $36.5 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $36.5 million, up 0.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.5 million (up 0.95% YoY), and the FY2025 annual result was $36.2 million, changed 0.22% from the prior year.
• Shares Outstanding (Weighted Average) came in at $36.5 million for Q1 2026 at Armata Pharmaceuticals, up from $36.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $36.5 million in Q1 2026 to a low of $20.5 million in Q4 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $36.1 million (2024), against an average of $33.8 million.
• Across the five-year window, Shares Outstanding (Weighted Average) soared 102.46% in 2022 and fell 29.13% in 2023, its largest moves.
• Armata Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $20.5 million in 2022, then surged by 75.56% to $36.1 million in 2023, then increased by 0.24% to $36.2 million in 2024, then advanced by 0.22% to $36.2 million in 2025, then rose by 0.8% to $36.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $36.5 million (Q1 2026), $36.2 million (Q4 2025), and $36.2 million (Q3 2025), per Business Quant data.